Importo totale (1 articolo articoli):
Destinazione ordine:
mills john lawrence corey (42 risultati)
Vai alla pagina principale dei risultati di ricerca
Filtri di ricerca
Tipo di articolo
- Tutti i tipi di prodotto
- Libri (42)
- Riviste e Giornali (Nessun altro risultato corrispondente a questo perfezionamento)
- Fumetti (Nessun altro risultato corrispondente a questo perfezionamento)
- Spartiti (Nessun altro risultato corrispondente a questo perfezionamento)
- Arte, Stampe e Poster (Nessun altro risultato corrispondente a questo perfezionamento)
- Fotografie (Nessun altro risultato corrispondente a questo perfezionamento)
- Mappe (Nessun altro risultato corrispondente a questo perfezionamento)
- Manoscritti e Collezionismo cartaceo (Nessun altro risultato corrispondente a questo perfezionamento)
Condizioni Maggiori informazioni
- Nuovo (31)
- Come nuovo, Ottimo o Quasi ottimo (7)
- Molto buono o Buono (4)
- Discreto o Mediocre (Nessun altro risultato corrispondente a questo perfezionamento)
- Come descritto (Nessun altro risultato corrispondente a questo perfezionamento)
Legatura
Ulteriori caratteristiche
- Prima ed. (2)
- Copia autograf. (Nessun altro risultato corrispondente a questo perfezionamento)
- Sovracoperta (1)
- Con foto (25)
- Non Print on Demand (28)
Lingua (2)
Spedizione gratuita
Paese del venditore
Valutazione venditore
-
Antiviral Chemotherapy
Editore: Elsevier Science Publishing Co., NY, 1986
Da: UHR Books, Hollis Center, ME, U.S.A.
Membro dell'associazione: MABA
Valutazione del venditore 5 su 5 stelle
Prima edizione
Hardcover. Condizione: Very Good. No Jacket. First Edition. "New directions for clinical application and research." Includes the proceedings from the conference held in San Francisco, from November 4-6, 1985. Several contributors. Indexed. Book.
-
Antiviral Chemotherapy 5. New Directions for Clinical Application and Research
Lingua: Inglese
Editore: Kluwer Academic/Plenum Publishers, c1999., New York, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Da: Research Ink, Takoma Park, MD, U.S.A.
Valutazione del venditore 4 su 5 stelle
Hardback. Condizione: Very Good. viii + 271 pp. Advances in Experimental Medicine and Biology5. Rubber-stamped on front free endpaper. book.
-
Antiviral Chemotherapy 5: New Directions for Clinical Application and Research [Advances in Experimental Medicine and Biology, Volume 458]
Lingua: Inglese
Editore: Kluwer Academic / Plenum Publishers, New York., 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Da: Tiber Books, Cockeysville, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Hardcover. Condizione: Very Good. 8vo, hardcover. No dj, as issued. Vg condition. Non-circulating ex-lib copy w/ label inside cover, exterior labels neatly removed (only markings); contents quite bright & clean, binding tight, covers glossy. viii, 271 p., illus. Proceedings of the Fifth Triennial Symposium on New Directions in Antiviral Chemotherapy, held November 13-15, 1997, in San Francisco, CA.
-
Antiviral Chemotherapy 4: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology) (v. 4)
Da: The Warm Springs Book Company, Fremont, CA, U.S.A.
Valutazione del venditore 5 su 5 stelle
Prima edizione
Hardcover. Condizione: Fine. 1st Edition. A fine copy issued without a DJ. Former owner's name on inside of front cover; slight trace of wear to pictorial boards; 1st edition with complete number line; illustrated; 8vo., 440 pages.
-
Antiviral Chemotherapy 4: New Directions for Clinical Application and Research
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 53,07
Spedizione EUR 13,84
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
-
Antiviral Chemotherapy 5: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology)
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 159,79
Spedizione EUR 13,84
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
-
Antiviral Chemotherapy 5: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology, 458)
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 159,79
Spedizione EUR 13,84
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
-
Antiviral Chemotherapy 5 : New Directions for Clinical Application and Research
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 159,78
Spedizione EUR 17,33
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Antiviral Chemotherapy 5 : New Directions for Clinical Application and Research
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 175,37
Spedizione EUR 2,27
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Antiviral Chemotherapy 5 : New Directions for Clinical Application and Research
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 179,54
Spedizione EUR 2,27
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
Antiviral Chemotherapy 5 : New Directions for Clinical Application and Research
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 181,24
Spedizione EUR 17,33
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
EUR 141,20
Spedizione EUR 70,00
Spedito da Germania a U.S.A.Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Antiviral Chemotherapy 5 | New Directions for Clinical Application and Research | John Mills (u. a.) | Taschenbuch | viii | Englisch | 2012 | Springer | EAN 9781461371502 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Antiviral Chemotherapy 4 : New Directions for Clinical Application and Research
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: New.
-
Antiviral Chemotherapy 4: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology, 394)
Da: California Books, Miami, FL, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 230,58
Spedizione gratuita
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Antiviral Chemotherapy 4 : New Directions for Clinical Application and Research
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 217,10
Spedizione EUR 17,33
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Antiviral Chemotherapy 4: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology, 394)
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 219,28
Spedizione EUR 13,84
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
-
Antiviral Chemotherapy 4: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology, 394)
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 219,28
Spedizione EUR 13,84
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
-
Antiviral Chemotherapy 5 : New Directions for Clinical Application and Research
Lingua: Inglese
Editore: Springer US, Springer New York, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
EUR 164,49
Spedizione EUR 62,66
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
-
Antiviral Chemotherapy 5 : New Directions for Clinical Application and Research
Lingua: Inglese
Editore: Springer US, Springer New York, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
EUR 168,73
Spedizione EUR 63,66
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
-
Antiviral Chemotherapy 5: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology, 458)
Da: Mispah books, Redhill, SURRE, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 247,47
Spedizione EUR 28,88
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. Like New. book.
-
Antiviral Chemotherapy 4 : New Directions for Clinical Application and Research
Lingua: Inglese
Editore: Springer, Springer New York, 1996
ISBN 10: 0306452944 ISBN 13: 9780306452949
EUR 223,11
Spedizione EUR 64,26
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed for VZV infections in some countries. Moreover. oral ganciclovir, cidofovir, and sorivudine are not far behind. Clinical trials with the second-site reverse transcriptase inhibitors and the protease inhibitors for HlV infection are proceeding rapidly and on a broad scale, and the preliminary results would suggest that several of these classes of drugs will be licensed as well. Despite this optimism, however, there is increasing evidence that antiviral-resistant strains of pathogenic viruses will be a significant problem, perhaps especially with therapy of HIV infection, and there remains a desperate need for improved drugs (with either improved efficacy or decreased toxicity, or both) for CMV and HIV infections. This book is the edited proceedings of the Fourth Triennial Conference on Antiviral Chemotherapy, held in San Francisco, in November 1994. The conference was sponsored by the University of California, San Francisco, and co-sponsored by the International Society for Antiviral Research (ISAR), the Macfarlane Burnet Centre for Medical Research in Melbourne, Australia, and the Australian National Centre for HIV Virology Research. The conference had been organized to present an overview of the field of antiviral chemotherapy.
-
EUR 238,59
Spedizione EUR 48,99
Spedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Proceedings of the Fourth Triennial Symposium held in San Francisco,California, November 10-12, 1994. The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the .
-
Antiviral Chemotherapy 4: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology)
Da: Revaluation Books, Exeter, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 303,10
Spedizione EUR 14,44
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. reprint edition. 454 pages. 9.25x6.10x1.03 inches. In Stock.
-
EUR 294,27
Spedizione EUR 63,43
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware - The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed for VZV infections in some countries. Moreover. oral ganciclovir, cidofovir, and sorivudine are not far behind. Clinical trials with the second-site reverse transcriptase inhibitors and the protease inhibitors for HlV infection are proceeding rapidly and on a broad scale, and the preliminary results would suggest that several of these classes of drugs will be licensed as well. Despite this optimism, however, there is increasing evidence that antiviral-resistant strains of pathogenic viruses will be a significant problem, perhaps especially with therapy of HIV infection, and there remains a desperate need for improved drugs (with either improved efficacy or decreased toxicity, or both) for CMV and HIV infections. This book is the edited proceedings of the Fourth Triennial Conference on Antiviral Chemotherapy, held in San Francisco, in November 1994. The conference was sponsored by the University of California, San Francisco, and co-sponsored by the International Society for Antiviral Research (ISAR), the Macfarlane Burnet Centre for Medical Research in Melbourne, Australia, and the Australian National Centre for HIV Virology Research. The conference had been organized to present an overview of the field of antiviral chemotherapy.
-
Antiviral Chemotherapy 4 : New Directions for Clinical Application and Research
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 358,11
Spedizione EUR 17,33
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
Antiviral Chemotherapy 4: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology) (v. 4)
Da: Mispah books, Redhill, SURRE, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 348,60
Spedizione EUR 28,88
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. Like New. book.
-
Antiviral Chemotherapy 4 : New Directions for Clinical Application and Research
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: As New. Unread book in perfect condition.
-
Antiviral chemotherapy: New directions for clinical application and research
Da: Mispah books, Redhill, SURRE, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 442,59
Spedizione EUR 28,88
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrellohardcover. Condizione: Very Good. Very Good. Dust Jacket may NOT BE INCLUDED.CDs may be missing. SHIPS FROM MULTIPLE LOCATIONS. book.
-
Antiviral Chemotherapy 4
Da: PBShop.store US, Wood Dale, IL, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 58,81
Spedizione gratuita
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
-
Antiviral Chemotherapy 4
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 54,07
Spedizione EUR 5,80
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
